The surge in biosimilars: considerations for effective pharmacovigilance and EU regulation

about

The surge in biosimilars: considerations for effective pharmacovigilance and EU regulation

Item

http://www.wikidata.org/entity/Q57135914

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

The surge in biosimilars: cons ...... acovigilance and EU regulation

@en

The surge in biosimilars: cons ...... acovigilance and EU regulation

@nl

type

Item

label

The surge in biosimilars: cons ...... acovigilance and EU regulation

@en

The surge in biosimilars: cons ...... acovigilance and EU regulation

@nl

prefLabel

The surge in biosimilars: cons ...... acovigilance and EU regulation

@en

The surge in biosimilars: cons ...... acovigilance and EU regulation

@nl

P1476

The surge in biosimilars: cons ...... acovigilance and EU regulation

@en

P2093

Begoña Calvo

http://www.w3.org/2001/XMLSchema#string

Enrique Echevarria

http://www.w3.org/2001/XMLSchema#string

Javier Martinez-Gorostiaga

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of the immune system in humans from infancy to old age

Basic facts about biosimilars.

Pharmacovigilance and biosimilars: considerations, needs and challenges.

The need for minimization strategies: current problems of immunosuppression.

Medical specialists' attitudes to prescribing biosimilars.

Eprex-associated pure red cell aplasia and leachates.

P304

601-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042098618790442

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30283628

http://www.w3.org/2001/XMLSchema#string

P932

6166315

http://www.w3.org/2001/XMLSchema#string